Timothy N. Showalter
蒂莫西·肖沃尔特
MD, MPH
Professor and Chair, Department of Radiation Oncology放射肿瘤学系主任兼教授
👥Biography 个人简介
Timothy Showalter is Chair of Radiation Oncology at the University of Virginia and a leading authority on brachytherapy for gynecologic and prostate cancers. He demonstrated that brachytherapy underutilization is associated with worse survival and has worked to expand access nationally.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Brachytherapy Access and Survival
Demonstrated that omission of brachytherapy boost in cervical cancer is associated with significantly inferior survival using SEER analyses.
Racial Disparities in Brachytherapy
Led research on racial and socioeconomic disparities in brachytherapy access, driving national advocacy for underserved patient populations.
MRI-Guided Adaptive Brachytherapy
Advanced MRI-guided adaptive brachytherapy techniques for locally advanced cervical cancer at University of Virginia.
Representative Works 代表性著作
Brachytherapy boost and survival in cervical cancer: National Cancer Data Base analysis
International Journal of Radiation Oncology Biology Physics (2014)
Showed brachytherapy boost associated with 12% improvement in 4-year survival vs EBRT alone.
Racial disparities in brachytherapy use among patients with cervical cancer
Gynecologic Oncology (2017)
Documented racial gaps in brachytherapy receipt, informing equity-focused guideline development.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Brian Marples
University of Rochester Medical Center
Silvia C. Formenti
Weill Cornell Medicine / NewYork-Presbyterian Hospital
Paul M. Harari
University of Wisconsin School of Medicine and Public Health
Jeff Forman
Wayne State University / Karmanos Cancer Institute
关注 蒂莫西·肖沃尔特 的研究动态
Follow Timothy N. Showalter's research updates
留下邮箱，当我们发布与 Timothy N. Showalter（University of Virginia School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment